Clinical Trial Update: PRotective Effect on the Coronary Microcirculation of Patients With DIabetes by Clopidogrel or Ticagrelor [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether clopidogrel or ticagrelor can protect the coronary microcirculation in patients with type 2 diabetes; the provide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Fundacion Investigacion Interhospitalaria Cardiovascular | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN